Pharmaceutical Packaging Development Matthew S. Thomas Associate - - PowerPoint PPT Presentation

pharmaceutical packaging development
SMART_READER_LITE
LIVE PREVIEW

Pharmaceutical Packaging Development Matthew S. Thomas Associate - - PowerPoint PPT Presentation

Pharmaceutical Packaging Development Matthew S. Thomas Associate Senior Consultant Engineer, Packaging Development Eli Lilly and Company October 2 nd , 2010 Technical, Quality and Supervisory Reviews Author Review : I confirm that the information in


slide-1
SLIDE 1

Pharmaceutical Packaging Development

Matthew S. Thomas

Associate Senior Consultant Engineer, Packaging Development Eli Lilly and Company October 2nd, 2010

slide-2
SLIDE 2

Technical, Quality and Supervisory Reviews

Author Review: I confirm that the information in this technical presentation is clearly written, scientifically accurate and does not contain any confidential information. ____________________________________________________________________________________________ Matthew S. Thomas, Assoc. Sr. Consultant Engineer, KY227 Date Technical Review: I have reviewed the information in this technical presentation and confirm it is clearly written and scientifically accurate. ____________________________________________________________________________________________ David Dziennik, Consultant Engineer, KY227 Date Quality Review: I have reviewed the information in this technical presentation and confirm it is clearly written and does not contain any confidential information. ____________________________________________________________________________________________ Harold Lowe, Assoc. Consultant QA Representative, KY114 Date Supervisory Review: I have reviewed the information in this technical presentation and confirm the listed author and reviewers are qualified to complete their activities. ____________________________________________________________________________________________ Randy Thackrey, Director, KY227 Date Matthew S. Thomas, Eli Lilly and Company 2

slide-3
SLIDE 3

Pharmaceutical Packaging Development

  • Packaging Components and Systems
  • Packaging Regulations
  • Performance Testing
  • Product Protection
  • Patient/User Centered Design

3 Matthew S. Thomas, Eli Lilly and Company

slide-4
SLIDE 4

Packaging Components and Systems

Primary Packaging Component: packaging component that provides product protection and contains materials of construction that come into contact with a pharmaceutical drug product. Critical Secondary Packaging Component: packaging component that provides product protection but does not contain materials of construction that come into contact with a pharmaceutical drug product.

4 Matthew S. Thomas, Eli Lilly and Company

slide-5
SLIDE 5

Packaging Components and Systems

Parenteral Packaging Components for Injection

5 Matthew S. Thomas, Eli Lilly and Company

slide-6
SLIDE 6

Packaging Components and Systems

Parenteral Packaging Systems for Injection

6 Matthew S. Thomas, Eli Lilly and Company

slide-7
SLIDE 7

Packaging Components and Systems

Dry Solid Oral Packaging Components

Matthew S. Thomas, Eli Lilly and Company 7

slide-8
SLIDE 8

Packaging Components and Systems

Matthew S. Thomas, Eli Lilly and Company 8

Dry Solid Oral Packaging Systems

slide-9
SLIDE 9

Packaging Regulations

Food Contact

– United States Code of Federal Regulations (CFR) – European Directives

Compendia Standards

– United States Pharmacopeia (USP) – European Pharmacopeia (PhEur) – Japanese Pharmacopeia (JP)

Performance Testing

– American Society for Testing and Materials (ASTM) – International Organization for Standardization (ISO) – International Safe Transit Association (ISTA) – United States and European Pharmacopeia

Matthew S. Thomas, Eli Lilly and Company 9

slide-10
SLIDE 10

Stability Testing (Product Protection)

– International Conference on Harmonization (ICH) – World Health Organization (WHO)

Food and Drug Administration (FDA) Guidance

– Container Closure System Suitability

  • Protection
  • Compatibility
  • Safety
  • Performance

Poison Prevention Packaging Act

  • Child Resistance and Senior Friendly

Matthew S. Thomas, Eli Lilly and Company 10

Packaging Regulations

slide-11
SLIDE 11

Performance Testing

Shipping and Distribution (Cold Chain)

Matthew S. Thomas, Eli Lilly and Company 11

Corrugated Shipping Container Gel Pack Insulation (e.g., expanded polystyrene)

slide-12
SLIDE 12

Performance Testing

Matthew S. Thomas, Eli Lilly and Company 12

Container Closure Integrity

Sealed Chambers Before Vacuum (1 ATM) Vacuum Applied

Seal Integrity No Seal Integrity

Vacuum / Pressure Decay

slide-13
SLIDE 13

Performance Testing

Matthew S. Thomas, Eli Lilly and Company 13

Water Vapor Transmission Rate (WVTR)

= Desiccant Temperature and Relative Humidity (RH) Controlled Chambers

Chamber Condition – 25C/60% RH

Inside Package

0% RH

Inside Package

0% RH

WVTR

mg H2 O/day

Chamber Condition – 25C/60% RH

WVTR

mg H2 O/day

slide-14
SLIDE 14

Matthew S. Thomas, Eli Lilly and Company 14

Performance Testing

Water Vapor Transmission Rate (WVTR)

Diffusion Sorption Desorption

Outside Package (high RH) Inside Package (low RH) WVTR

H2 O H2 O

Plastic Wall Cross Section

PET Bottles HDPE Bottles Typical Blister Laminate PVC PVDV

slide-15
SLIDE 15

ICH and WHO Stability Conditions

  • Zone I and II Countries (Temperate & Subtropical/Mediterranean)

– Real time storage at 25C/60%RH

  • Zone III and IV Countries (Hot/Dry & Hot/Humid)

– Real time storage at 30C/65%RH or 30C/75%RH

Matthew S. Thomas, Eli Lilly and Company 15

Product Protection (stability testing)

slide-16
SLIDE 16

Matthew S. Thomas, Eli Lilly and Company 16

Patient/User Centered Design

slide-17
SLIDE 17

Matthew S. Thomas, Eli Lilly and Company 17

Patient/User Centered Design

slide-18
SLIDE 18

Matthew S. Thomas, Eli Lilly and Company 18

Patient/User Centered Design

slide-19
SLIDE 19

Matthew S. Thomas, Eli Lilly and Company 19

Patient/User Centered Design

slide-20
SLIDE 20

Matthew S. Thomas, Eli Lilly and Company 20

Patient/User Centered Design